Abstract
Objectives
Comparing breast cancer screening across countries within the context of some of the benefits and harms offers the opportunity to improve effectiveness through mutual learning.
Methods
This paper describes the provision of breast cancer screening in England and the United States. The various recommendations for accessing breast cancer screening in the two countries are set out and the organisation of services including quality assurance, incentives and performance mechanisms considered.
Results
In the United States, younger women are routinely screened; they are less likely to benefit and more likely to be harmed. The utilisation of breast cancer screening amongst eligible women is broadly comparable in the two countries. However, there are differences in technical performance; the reasons for these including radiological reading procedures and cultural factors are explored.
Conclusions
Despite a well-functioning screening programme, breast cancer mortality and survival in England are poor relative to other countries. Emphasis for American improvement should be on reducing false-positive recall rates, while the English NHS could supplement existing efforts to understand and improve comparatively poor survival and mortality.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Cancer Society (2014a) Medicare coverage for cancer prevention and early detection. http://www.cancer.org/healthy/findcancerearly/cancerscreeningguidelines/medicare-coverage-for-cancer-prevention-and-early-detection. Accessed 10 Aug 2014
American Cancer Society (2014b) Breast cancer: early detection. http://www.cancer.org/acs/groups/cid/documents/webcontent/003165-pdf.pdf. Accessed 30 Oct 2014
American College of Obstetricians and Gynecologists (2011) Breast cancer screening. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); Aug 11 p (ACOG practice bulletin; no. 122)
American College of Radiology (2014) Mammography Accreditation Program requirements. http://www.acr.org/~/media/ACR/Documents/Accreditation/Mammography/Requirements.pdf. Accessed 10 Aug 2014
Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE (2007) Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med 146(7):516–526
Autier P, Boniol M, Gavin A, Vatten LJ (2011) Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ 343:d4411
Bewley S (2011) The NHS breast screening programme needs independent review. BMJ 343:d6894
Blanks RG, Day NE, Moss SM (1996) Monitoring the performance of breast screening programmes: use of indirect standardisation in evaluating the invasive cancer detection rate. J Med Screen 3(2):79–81
Bond M, Pavey T, Welch K, Cooper C, Garside R, Hyde C (2013) Systematic review of the psychological consequences of false-positive screening mammograms. Evid Based Med 18:54–61
Buist DS, Anderson ML, Haneuse SJ, Sickles EA, Smith RA, Carney PA, Taplin SH, Rosenberg RD, Geller BM, Onega TL, Monsees BS, Bassett LW, Yankaskas BC, Elmore JG, Kerlikowske K, Miglioretti DL (2011) Influence of annual interpretive volume on screening mammography performance in the United States. Radiology 259(Issue 1):72–84
Burnside ES, Sickles EA, Sohlich RE, Dee KE (2002) Differential value of comparison with previous examinations in diagnostic versus screening mammography. AJR 179:1173–1177
Cassels A (2012) Seeking Sickness. Greystone Books, Vancouver
Centers for Disease Control and Prevention (2012) National Centre for Health Statistics, National Health Interview Survey. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6103a1.htm. Accessed 10 Aug 2014
Centers for Disease Control and Prevention (2014b) What screening tests are there? http://www.cdc.gov/cancer/breast/basic_info/screening.htm. Accessed 10 Aug 2014
Centers for Disease Control and Prevention (2014) National Breast and Cervical Cancer Early Detection Program. http://www.cdc.gov/cancer/nbccedp/about.htm. Accessed 10 Aug 2014
Centers for Medicare and Medicaid Services (2014a). http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ACO/. Accessed 10 Aug 2014
Centers for Medicare and Medicaid Services (2014b) Accountable Care Organization 2014 program analysis quality performance standards narrative measure specifications. http://www.cms.gov/medicare/medicare-fee-for-service-payment/sharedsavingsprogram/downloads/aco-narrativemeasures-specs.pdf. Accessed 30 Oct 2014
Cohen RA, Martinez ME (2013) Health insurance coverage: early release of estimates from the National Health Interview Survey, 2012. National Center for Health Statistics. http://www.cdc.gov/nchs/data/nhis/earlyrelease/insur201306.pdf. Accessed 10 Aug 2014
Department of Health (2013) Public health functions to be exercised by NHS England, service specification No.24: Breast Screening Programme. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/192975/24_Breast_Screening_Programme__service_specification_VARIATION__130422_-NA.pdf. Accessed 30 Oct 2014
Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW (1998) Ten-year risk of false positive screening mammograms and clinical breast examination. New Eng J Med 338:1089–1096
Elmore JG, Nakano CY, Koepsell TD, Desnick LM, D’Orsi CJ, Ransohoff DF (2003) International variation in screening mammography interpretations in community-based programs. J Natl Cancer Inst 95(18):1384–1393
Elmore JG, Armstrong K, Lehman CD, Fletcher SW (2005a) Screening for breast cancer. JAMA 293:1245–1256
Elmore JG, Taplin SH, Barlow WE, Cutter GR, D’Orsi CJ, Hendrick RE, Abraham LA, Fosse JS, Carney PA (2005b) Does litigation influence medical practice? The influence of community radiologists’ medical malpractice perceptions and experience on screening mammography. Radiology 236(1):37–46
Elmore JG, Jackson SL, Abraham L, Miglioretti DL, Carney PA, Geller BM, Yankaskas BC, Kerlikowske K, Onega T, Rosenberg RD, Sickles EA, Buist DS (2009) Variability in interpretive performance at screening mammography and radiologists’ characteristics associated with accuracy. Radiology 253(3):641–651
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917
Foot C, Harrison T (2011) How to improve cancer survival: explaining England’s relatively poor rates. The King’s Fund, London
Garvican L, Field S (2001) A pilot evaluation of the R2 image checker system and users’ response in the detection of interval breast cancers on previous screening films. Clin Radiol 56(10):833–837
Gerber AS, Patashnik EM, Doherty D, Dowling C (2010) A national survey reveals public skepticism about research-based treatment. Health Aff 29(10):1882–1884
Gilliland FD, Joste N, Stauber PM, Hunt WC, Rosenberg R, Redlich G, Key CR (2000) Biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst 92(9):743–749
Goossens M, Van Hal G, Van der Burg M, Kellen E, Van Herck K, De Grève J, Martens P, Van Limbergen E (2014) Quantifying independent risk factors for failing to rescreen in a breast cancer screening program in Flanders, Belgium. Prev Med 69:280–286
Hofvind S, Geller BM, Skelly J, Vacek PM (2012) Sensitivity and specificity of mammographic screening as practiced in Vermont and Norway. Br J Radiol 85(1020):e1226–e1232
Howard DH, Adams EK (2012) Mammography rates after the 2009 US Preventive Services Task Force breast cancer screening recommendation. Prev Med 55(5):485
Information Centre for Health and Social Care (2014) Breast Screening Programme, England, 2012–2013. http://www.hscic.gov.uk/catalogue/PUB13567. Accessed 10 Aug 2014
Kalager M, Zelen M, Langmark F, Adami HO (2010) Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 363:1203–1210
Lambert PC, Holmberg L, Sandin F, Bray F, Linklater KM, Purushotham A, Robinson D, Møller H (2011) Quantifying differences in breast cancer survival between England and Norway. Cancer Epidemiol 35(6):526–533
Levy AR, Bruen BK, Ku L (2012) Health care reform and women’s insurance coverage for breast and cervical cancer screening. Prev Chronic Dis 9:1545–1551 (E159)
Mainiero MB, Lourenco A, Mahoney MC, Newell MS, Bailey L, Barke LD, D’Orsi C, Harvey JA, Hayes MK, Huynh PT, Jokich PM, Lee SJ, Lehman CD, Mankoff DA, Nepute JA, Patel SB, Reynolds HE, Sutherland ML, Haffty BG (2013) ACR appropriateness criteria breast cancer screening. J Am Coll Radiol 10(1):11–14. doi:10.1016/j.jacr.2012.09.036
Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, White E (2000) Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 92(13):1081–1087
Mavroforou A, Mavrophorosb D, Michalodimitrakisa E (2006) Screening mammography, public perceptions, and medical liability. Eur J Radiol 57(3):428–435
Miller JW, King JB, Joseph DA, Richardson LC, Centers for Disease Control and Prevention (2012) Breast cancer screening among adult women—Behavioral Risk Factor Surveillance System, United States 2010. MMWR Morb Mortal Wkly Rep 61(Suppl):46–50
Møller H, Sandin F, Bray F, Klint A, Linklater KM, Purushotham A, Robinson D, Holmberg L (2010) Breast cancer survival in England, Norway and Sweden: a population-based comparison. Int J Cancer 127(11):2630–2638
National Cancer Institute (2014) Mammograms factsheet. http://www.cancer.gov/cancertopics/factsheet/detection/mammograms. Accessed 10 Aug 2014
National Institute for Health and Care Excellence (2013) Familial breast cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer
National Institute for Health and Care Excellence (2014) The Quality and Outcomes Framework. http://www.nice.org.uk/standards-and-indicators?tab=qof. Accessed 30 Oct 2014
National Research Council (2005) Improving breast imaging quality standards. The National Academies Press, Washington
NHS Breast Cancer Screening Programme (2005) Consolidated guidance on standards for the NHS Breast Screening Programme. http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp60.html. Accessed 30 Oct 2014
NHS Breast Cancer Screening Programme (2010) Age extension full randomised control trial. http://www.cancerscreening.nhs.uk/breastscreen/research-age-extension-full-rct-faqs.html. Accessed 10 Aug 2014
NHS Breast Screening Programme (2002) New ways of working: second report on implementation. http://www.cancerscreening.nhs.uk/breastscreen/publications/radiography.html. Accessed 10 Aug 2014
NHS Breast Screening Programme (2013) Guidelines on organising the surveillance of women at higher risk of developing breast cancer in an NHS Breast Screening Programme
NHS Cancer Screening Programmes (2011) Quality assurance guidelines for breast cancer screening radiology, second edition
NHS Cancer Screening Programmes (2012) NHS Breast Screening Programme 2012 annual review. http://www.cancerscreening.nhs.uk/breastscreen/publications/2012review.html. Accessed 10 Aug 2014
Onega T, Aiello Bowles EJ, Miglioretti DL, Carney PA, Geller BM, Yankaskas BC, Kerlikowske K, Sickles EA, Elmore JG (2010) Radiologists’ perceptions of computer aided detection versus double reading for mammography interpretation. Acad Radiol 17(10):1217–1226
Pace LE, He Y, Keating NL (2013) Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer 119(14):2518–2523
Raffle AE, Gray JAM (2007) Screening: evidence and practice. Oxford University Press, Oxford
Rauscher GH, Johnson TP, Cho YI, Walk JA (2008) Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev 17(4):748–757
Richards M (2011) An independent review is under way. BMJ 343:d6843
Roelofs AA, Karssemeijer N, Wedekind N, Beck C, van Woudenberg S, Snoeren PR, Hendriks JH, Rosselli del Turco M, Bjurstam N, Junkermann H, Beijerinck D, Séradour B, Evertsz CJ (2007) Importance of comparison of current and prior mammograms in breast cancer screening. Radiology 242(1):70–77
Schwartz LM, Woloshin S, Fowler FJ, Welch HG (2004) Enthusiasm for cancer screening in the United States. JAMA 291(1):71–78
Sharpe RE, Levin DC, Parker L, Rao VM (2013) The effect of the controversial US Preventive Services Task Force recommendations on the use of screening mammography. J Am Coll Radiol 10(1):21–24
Smith RA, Saslow D, Sawyer KA, Burke W, Costanza ME, Evans WP 3rd, Foster RS Jr, Hendrick E, Eyre HJ, Sener S, American Cancer Society High-Risk Work Group, American Cancer Society Screening Older Women Work Group; American Cancer Society Mammography Work Group; American Cancer Society Physical Examination Work Group; American Cancer Society New Technologies Work Group; American Cancer Society Breast Cancer Advisory Group (2003) American Cancer Society guidelines for breast cancer screening: update 2003. Women’s Health Research Faculty Publications
Smith-Bindman R, Ballard-Barbash R, Miglioretti DL, Patnick J, Kerlikowske K (2005) Comparing the performance of mammography screening in the USA and the UK. J Med Screen 12:1
Squires DA (2012) Explaining high health care spending in the United States: an international comparison of supply, utilization, prices, and quality. Commonwealth Fund
Stubbs JW (2009) Statement on the politicization of evidence-based clinical research, in American College of Physicians (database online). http://www.acponline.org/pressroom/pol_ebcr.htm?hp. Accessed 10 Aug 2014
Tabár L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, Chiu SY, Chen SL, Fann JC, Rosell J, Fohlin H, Smith RA, Duffy SW (2011) Swedish two-county Trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 260(3):658–663. doi:10.1148/radiol.11110469 (Epub 2011 Jun 28)
Taylor P, Potts HWW (2008) Computer aids and human second reading as interventions in screening mammography: two systematic reviews to compare effects on cancer detection and recall rate. Eur J Cancer 44(6):798–807
The Independent UK Panel on Breast Cancer Screening (2012) The benefits and harms of breast cancer screening: an independent review. Cancer Research UK and the Department of Health, London
United States Preventive Services Task Force (2002) Screening for breast cancer. http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/breast-cancer-screening-2002. Accessed 10 Aug 2014
United States Preventive Services Task Force (2009) Screening for breast cancer. http://www.uspreventiveservicestaskforce.org/uspstf/uspsbrca.htm. Accessed 10 Aug 2014
U.S. Food and Drug Administration (2002) Mammography Quality Standards Act Regulations, Sec. 900.12 quality standards. http://www.fda.gov/Radiation-EmittingProducts/MammographyQualityStandardsActandProgram/Regulations/ucm110906.htm. Accessed10 Aug 2014
U.S. Food and Drug Administration (2005) Mammography facility surveys, mammography equipment evaluations, and medical physicist qualification requirements under MQSA. http://www.fda.gov/downloads/MedicalDevices/…/ucm094411.pdf. Accessed 30 Oct 2014
Walters S, Maringe C, Butler J, Rachet B, Barrett-Lee P, Bergh J, Boyages J, Christiansen P, Lee M, Wärnberg F, Allemani C, Engholm G, Fornander T, Gjerstorff ML, Johannesen TB, Lawrence G, McGahan CE, Middleton R, Steward J, Tracey E, Turner D, Richards MA, Coleman MP, ICBP Module 1 Working Group (2013) Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000–2007: a population-based study. Br J Cancer 108(5):1195–1208
Welch GH, Schwartz L, Woloshin S (2011) Overdiagnosed: making people sick in the pursuit of health. Beacon Press, Boston
Wilson RM (2000) Screening for breast and cervical cancer as a common cause for litigation. BMJ Int Edit 320(7246):1352–1353
Wilson MG, Lavis JN (2013) Evidence brief: supporting optimal screening approaches in Canada. McMaster Health Forum, Hamilton
Woolf SH (2010) The 2009 breast cancer screening recommendations of the US Preventive Services Task Force. JAMA 303(2):162–163
Yankaskas BC, May RC, Matuszewski J, Bowling JM, Jarman MP, Schroeder BF (2011) Effect of observing change from comparison mammograms on performance of screening mammography in a large community-based population. Radiology 261:762–770
Youlden DR, Cramb SM, Dunn NAM, Muller JM, Pyke CM, Baade PD (2012) The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 36:237–248
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None of the authors declared any conflicts of interest.
Rights and permissions
About this article
Cite this article
Williams, J., Garvican, L., Tosteson, A.N.A. et al. Breast cancer screening in England and the United States: a comparison of provision and utilisation. Int J Public Health 60, 881–890 (2015). https://doi.org/10.1007/s00038-015-0740-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00038-015-0740-5